PARSIPPANY, N.J., July 24, 2025 /PRNewswire/ — Scopio Labs, developer of Full-Field Cell Morphology imaging and analysis platform, announced today the unveiling of its groundbreaking Complete Blood Morphology (CBM®) analyzer. CBM will bring unprecedented scale, efficiency and standardization to hematology through autonomous morphology analysis and reporting, one of the last remaining manual processes in diagnostics. To expedite the go-to-market of CBM®, Viola Growth has joined as a new investor with a $10 million extension to Scopio’s Series D funding, bringing the total to $52 million.
Read more here.